Showing results (101-110 of 260) with videos related to
Sort By:
Pageof 26
Haematology and Blood Transfusion|January 1, 1977
Etiological, clinical and prognostic significance of the T-B immunological classification of primary acute lymphoid leukemias and non Hodgkin's lymphomasD Belpomme, N Lelarge, G Mathé, et al.Immunopharmacology|August 1, 1985
Aclacinomycin-A inhibits the development and the expression of suppressor cell activity to contact sensitivityC E Andrade-Mena, S Orbach-Arbouys, G MathéChemotherapy|January 1, 1986
Enhancement of NK-cell activity in normal and tumor-bearing mice after administration of aclacinomycinC E Andrade Mena, S Orbach-Arbouys, G MathéBiomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1978
Non-H-2 antigens can induce high GVH mortality in adult recipients of normal cellsO Halle-Pannenko, L L Pritchard, R Motta, et al.Israel Journal of Medical Sciences|April 1, 1976
Monitoring of nonspecific cell-mediated immunity in cancer patients. I. Frequent dissociation between the responses of skin tests to recall antigens and in vitro lymphocyte transformationM C Simmler, G Rameau, M J Chou, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1995
Lysosomal exocytosis induced by hyperthermia: a new model of cancer cell death. II. Effect on peritoneal macrophagesP Pontiggia, S Barni, G Mathé, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
Will killing the last HIV1 particle cure AIDS patients? II: Second Part. Decrease of viral load and of T-suppressor cells, and increase of the cytotoxic cells, without effect on CD4, after the use of 10 virostatics applied in 3 or 4 drug combinations of different sequences. The time for CD4 immunotherapy?G Mathé, U Colasanté, C Morette, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 12, 2002
Polyphenols: do they play a role in the prevention of human pathologies?H Tapiero, K D Tew, G Nguyen Ba, et al.Israel Journal of Medical Sciences|April 1, 1976
Methanol extraction residue fraction of tubercle bacilli (MER) and other mycobacterial extracts as systemic immunity adjuvants in cancer immunotherapyG Mathé, I J Hiu, O Halle-Pannenko, et al.La Nouvelle Presse Medicale|July 2, 1977
[Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome?]J L Misset, A M Venuat, L Nevarez, et al.Pageof 26